OMERS Administration Corp’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-175,900	Closed	-$269K	–	867
2025 Q1	$269K	Buy	175,900 +121,500	+223%	+$186K	﹤0.01%	879
2024 Q4	$135K	Buy	+54,400	New	+$135K	﹤0.01%	892
2019 Q2	–	Sell	-25,400	Closed	-$158K	–	383
2019 Q1	$158K	Buy	+25,400	New	+$158K	﹤0.01%	347